Healthleap has raised $38 million for software that screens hospital records for patients who may have overlooked conditions. The financing combines an $8 million seed round led by Sequoia Capital and First Round Capital with a $30 million Series A led by Hummingbird Ventures.
The system analyzes structured fields such as laboratory results, weight and vital signs alongside clinicians’ notes. It looks for affirmative or negated mentions of signs including poor appetite, recent weight loss, muscle loss and difficulty swallowing. Healthleap says the platform is deployed in more than 50 hospitals to screen for malnutrition and delirium. Programs for aspiration pneumonia, pressure ulcers and readmission risk in congestive heart failure are still being developed.
The company began in South Africa in 2022 with a nutrition tool before expanding to broader clinical screening. Its software flags records for closer attention; the reported use does not make it a diagnosis or replace a clinician’s judgment. The funding will support a product aimed at an important gap in hospital care: relevant clues can be scattered between numeric fields and free-text notes, making at-risk patients harder to identify early.